OneAscent Family Office LLC Takes $405,000 Position in STERIS plc (NYSE:STE)

OneAscent Family Office LLC bought a new position in shares of STERIS plc (NYSE:STE - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,791 shares of the medical equipment provider's stock, valued at approximately $405,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Diversify Advisory Services LLC lifted its stake in STERIS by 36.2% during the first quarter. Diversify Advisory Services LLC now owns 2,101 shares of the medical equipment provider's stock worth $471,000 after purchasing an additional 558 shares during the last quarter. Dynasty Wealth Management LLC raised its holdings in STERIS by 15.9% during the first quarter. Dynasty Wealth Management LLC now owns 1,172 shares of the medical equipment provider's stock worth $266,000 after purchasing an additional 161 shares in the last quarter. Victory Capital Management Inc. lifted its position in shares of STERIS by 3.7% during the 1st quarter. Victory Capital Management Inc. now owns 72,992 shares of the medical equipment provider's stock worth $16,544,000 after buying an additional 2,591 shares during the last quarter. Larson Financial Group LLC boosted its holdings in shares of STERIS by 64.8% in the 1st quarter. Larson Financial Group LLC now owns 389 shares of the medical equipment provider's stock valued at $88,000 after buying an additional 153 shares in the last quarter. Finally, Wealthfront Advisers LLC boosted its holdings in shares of STERIS by 53.4% in the 1st quarter. Wealthfront Advisers LLC now owns 2,883 shares of the medical equipment provider's stock valued at $653,000 after buying an additional 1,004 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company's stock.

Wall Street Analyst Weigh In

STE has been the topic of several research analyst reports. Jefferies Financial Group assumed coverage on shares of STERIS in a research note on Thursday, May 29th. They set a "hold" rating and a $263.00 price target on the stock. Needham & Company LLC restated a "hold" rating on shares of STERIS in a research note on Monday, April 7th. Wall Street Zen cut STERIS from a "strong-buy" rating to a "buy" rating in a research report on Friday. Morgan Stanley raised STERIS from an "equal weight" rating to an "overweight" rating and boosted their target price for the company from $260.00 to $276.00 in a report on Tuesday, July 15th. Finally, Stephens reissued an "overweight" rating and issued a $250.00 target price on shares of STERIS in a research report on Thursday, May 15th. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $266.50.

Insider Activity at STERIS

In other news, SVP Cary L. Majors sold 12,828 shares of the firm's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $250.08, for a total value of $3,208,026.24. Following the completion of the sale, the senior vice president owned 11,372 shares in the company, valued at approximately $2,843,909.76. This trade represents a 53.01% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Daniel A. Carestio sold 17,626 shares of STERIS stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $242.56, for a total transaction of $4,275,362.56. Following the completion of the sale, the chief executive officer directly owned 51,385 shares in the company, valued at approximately $12,463,945.60. The trade was a 25.54% decrease in their position. The disclosure for this sale can be found here. 1.07% of the stock is owned by corporate insiders.

STERIS Stock Performance

STERIS stock traded up $0.82 during midday trading on Friday, hitting $225.41. 1,721,770 shares of the company's stock were exchanged, compared to its average volume of 564,453. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.39 and a current ratio of 1.96. The stock has a market cap of $22.17 billion, a price-to-earnings ratio of 36.36 and a beta of 0.92. STERIS plc has a 12-month low of $200.98 and a 12-month high of $252.79. The firm's 50 day simple moving average is $238.70 and its 200 day simple moving average is $226.86.

STERIS (NYSE:STE - Get Free Report) last announced its earnings results on Wednesday, May 14th. The medical equipment provider reported $2.74 earnings per share for the quarter, topping the consensus estimate of $2.59 by $0.15. The business had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.47 billion. STERIS had a net margin of 11.26% and a return on equity of 14.21%. The business's quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.58 earnings per share. Equities research analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 26th. Stockholders of record on Tuesday, June 10th were issued a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.01%. The ex-dividend date was Tuesday, June 10th. STERIS's payout ratio is currently 36.77%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.